Suven Pharmaceuticals Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

1185.15

-31.35 (-2.58%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

1185.15

-31.35 (-2.58%)
16:02 Dec 20

Quality

54/100
Medium Financial Strength

Valuation

9/100
Expensive Valuation

Technical

55/100
Technically Neutral

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM 2024
Net Sales	1009.72	1320.22	1340.33	1051.35	961.16
Operating Expenses +	569.24	740.79	773.79	645.54	638.74
Raw Material	310.32	459.46	430.08	265.88	220.34
Increase Decrease in Cost	-8.37	-60.35	-20.94	49.16	51.49
Other Manufacturing Expense	122.73	173.19	176.29	133.48	0
Employee Cost	87.29	100.48	110.51	135.92	169.71
Miscellaneous Expenses	57.27	68.01	77.85	61.1	197.2
Operating Profit	440.48	579.43	566.54	405.81	322.42
Other Income	14.24	92.38	46.36	61.91	63.67
Depreciation	31.64	39.1	47.73	54.6	60.36
Interest	9.14	6.23	5.44	7.45	6.84
Profit before tax and exceptio..	413.94	626.48	559.73	405.67	318.89
Exceptional Items	0	0	0	0	0
PBT	413.94	626.48	559.73	405.67	318.89
Provision for Taxation	105.33	213.78	148.44	105.39	76.03
Net Profit	308.61	412.69	411.29	300.28	242.87
NET Profit after MI	362.34	453.8	411.29	300.28	243.1
EPS	14.23	17.83	16.16	11.8	9.56
Operating Profit Margin (%)	43.62	43.89	42.27	38.6	33.54
Net Profit Margin (%)	35.89	34.37	30.69	28.56	25.29

ShareHolding

All Data in Percentage (%)

	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23
Promoter	50.10	50.10	50.10	60.00	60.00
FII	10.70	9.80	9.50	10.10	10.00
MF	14.10	14.80	15.30	13.40	12.20
Public	22.30	22.70	23.10	13.90	15.80
Others	0.00	0.00	0.00	0.00	0.00
Others	2.80	2.60	2.00	2.60	2.00